Recent in vitro evidence suggests two alternative mechanisms by which
bone marrow-derived APCs may process exogenous antigens for presentati
on to CTL in vivo, a phenomenon termed cross-priming. Although in vitr
o studies have suggested that both TAP-dependent and TAP-independent p
athways exist, we have now demonstrated an absolute requirement for a
functional TAP for cross-priming to occur in vivo. Bone marrow chimera
s reconstituted with marrow from TAP-defective donors develop function
al CD8(+) CTL, but have APCs with disrupted TAP function. In such chim
eras, in vivo priming of naive CTL was observed when antigen was targe
ted to the ER in a TAP-independent fashion, but cross-priming could no
t be demonstrated. These results support the TAP-dependent mechanism o
f cross-priming.